These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 4064045)
1. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions. Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
3. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions. Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology. Whiteside TL; Dekker A Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy. Gandhi AK; Nayar M; Bihari N; Chandra M Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin. Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904 [TBL] [Abstract][Full Text] [Related]
7. [Carcinoembryonic antigen in ascites and pleural effusions]. Lirzin P; Zeitoun P; Vandromme L; Salas H Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557 [TBL] [Abstract][Full Text] [Related]
8. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions. Sehested M; Ralfkjaer E; Rasmussen J Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401 [TBL] [Abstract][Full Text] [Related]
9. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY; Li GD; Liu HB; Jiang LL Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [TBL] [Abstract][Full Text] [Related]
10. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer. Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of the determination of carcinoembryonic antigens with monoclonal antibodies in abdominal and pleural effusion]. Fei XF Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):28-9, 62. PubMed ID: 2379252 [TBL] [Abstract][Full Text] [Related]
12. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)]. Gulyás M; Elek G; Molnár M; Szollár L Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550 [TBL] [Abstract][Full Text] [Related]
13. [Differential diagnosis of pleural effusions]. Ogino M; Koike K; Satoh K; Arai K Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions]. Yang Z; Xie C Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962 [TBL] [Abstract][Full Text] [Related]
15. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients. Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732 [TBL] [Abstract][Full Text] [Related]
17. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme. Kyrkou KA; Iatridis SG; Athanassiadou PP; Emmanouilidou AG; Athanassiadis PP Acta Cytol; 1985; 29(1):57-62. PubMed ID: 3881880 [TBL] [Abstract][Full Text] [Related]
19. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670 [TBL] [Abstract][Full Text] [Related]
20. Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates. Walts AE; Said JW Acta Cytol; 1983; 27(4):408-16. PubMed ID: 6410636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]